On 21 October, staff from the Food and Drug Administration's (FDA) Office of In Vitro Devices met with staff from various clinical laboratory organizations and professional societies, including ASM, for the FDA/Professional Society Roundtable Meeting.
A letter was sent in October from medical research organizations, including ASM, asking Congress to approve the fiscal year (FY) 2011 appropriation for the Department of Health and Human Services and to support the $1 billion increase for the National Institutes of Health proposed in the President's budget request to Congress.
Ronald Atlas, cochair of the ASM Public and Scientific Affairs Board Biodefense Committee, made a presentation on codes of conduct and dual use research of concern (DURC) on 20 October to the National Science Advisory Board on Biosecurity (NSABB).
The ASM signed onto two coalition letters to the Food and Drug Administration (FDA) regarding the possible regulation of Laboratory Developed Tests (LDTs).
Alice Weissfeld, member of the PSAB Committee on Professional Affairs, represented ASM at the National Laboratory Response Network (LRN) meeting in San Diego, Calif., 13-15 October.
Vickie Baselski, chair of the ASM Public and Scientific Affairs Board Committee on Professional Affairs, attended a meeting of the Coordinating Committee for the Clinical Laboratory Workforce (CCCLW) on 13 September.